NEW YORK, March 8, 2018 /PRNewswire/ — According to data published by Ameri Research Inc. the global legal marijuana market was valued at $14.3 billion in 2016 and is forecast to grow at a CAGR of 21.1% between 2017 and 2024, culminating in 2024 global sales of $63.5 billion. The legal cannabis market is witnessing healthy growth due to the increasing legalization and decriminalization of cannabis products across North America and Europe. The report also indicates that due to the complex regulatory structure at state level and federal level, the full potential of the market is not yet realized. On January 1st the state of California has joined the short list of states where sales of recreational cannabis are legal. Cannabis Strategic Ventures Inc. (OTC: NUGS), GB Sciences, Inc. (OTC: GBLX), mCig, Inc. (OTC: MCIG), Abattis Bioceuticals Corp. (OTC: ATTBF), Vitality Biopharma, Inc. (OTC: VBIO)

The potential financial benefits from the legalization are important economically and politically. Fortune reported that, “in order to collect $1 billion a year in taxes, the state will need to reach a projected $7 billion in annual legal recreational cannabis sales. At that rate, California would easily be the country’s largest legal marijuana market, as the entire legal cannabis industry in the U.S. is expected to pull in roughly $10 billion in total sales for 2017. That number would almost certainly get a boost in the coming years, as legal markets grow in California and other states, such as Nevada and Massachusetts.”

Cannabis Strategic Ventures Inc. (OTC: NUGS) just late yesterday the company announced breaking news that, “the signing of staffing agreement between the two companies today.  Under the terms of the agreement, Cannabis Strategic Ventures will provide long term staffing functions, benefits management, payroll processing and outsourced employment on behalf

Read More Here...